Structure |
Chemical Name |
CAS |
MF |
![(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine](/CAS/20210111/GIF/324023-99-6.gif) |
(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine |
324023-99-6 |
C20H23NO3 |
![Solifenacin Impurity 4(Solifenacin EP Impurity H)](/CAS/20200515/GIF/732228-02-3.gif) |
Solifenacin Impurity 4(Solifenacin EP Impurity H) |
732228-02-3 |
C23H26N2O2 |
![849217-77-2](/CAS/20200515/GIF/849217-77-2.gif) |
849217-77-2 |
849217-77-2 |
C22H20N2O6 |
![1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-](/CAS/20211123/GIF/1675248-18-6.gif) |
1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- |
1675248-18-6 |
C18H25N5O3 |
![Amlodipine iMpurity L](/CAS/20180529/GIF/1821498-25-2.gif) |
Amlodipine iMpurity L |
1821498-25-2 |
C17H19ClN2O5 |
![(6R,7R)-7-[(2,2-dimethylpropanoyl)amino]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](/CAS/20180703/GIF/CB43155163.gif) |
(6R,7R)-7-[(2,2-dimethylpropanoyl)amino]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
2384108-14-7 |
C16H20N4O4S3 |
![methyl (41R,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20211123/GIF/58000-63-8.gif) |
methyl (41R,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
58000-63-8 |
C21H26N2O3 |
![(S)-ethyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate](/CAS/20180529/GIF/1392015-05-2.gif) |
(S)-ethyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate |
1392015-05-2 |
C17H15F5NO5P |
![3-(2-cyclopentylidene-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide](/CAS/20180703/GIF/CB43159060.gif) |
3-(2-cyclopentylidene-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide |
|
C19H26BrNO2 |
![Cephalexin Impurity 3](/CAS/20180703/GIF/CB43159222.gif) |
Cephalexin Impurity 3 |
|
C16H17N3O4S |
![8-Methoxy Entecavir](/CAS/20210111/GIF/2203740-23-0.gif) |
8-Methoxy Entecavir |
2203740-23-0 |
C13H17N5O4 |
![Bortezomib Impurity 32](/CAS/20180906/GIF/1310383-72-2.gif) |
Bortezomib Impurity 32 |
1310383-72-2 |
C17H31BF3NO5 |
![Topiroxostat Impurity 14](/) |
Topiroxostat Impurity 14 |
|
|
![1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4S)-](/CAS/20180529/GIF/401564-34-9.gif) |
1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4S)- |
401564-34-9 |
C13H22N2O4S |
![Ampicillin Impurity B](/) |
Ampicillin Impurity B |
|
|
![Clindamycin Phosphate EP Impurity K](/) |
Clindamycin Phosphate EP Impurity K |
|
|
![7,7'-(butane-1,4-diylbis(oxy))bis(quinolin-2(1H)-one)](/CAS/20180529/GIF/2116542-19-7.gif) |
7,7'-(butane-1,4-diylbis(oxy))bis(quinolin-2(1H)-one) |
2116542-19-7 |
C22H20N2O4 |
![Descyclopropyl Lenvatinib](/CAS/20200515/GIF/417719-51-8.gif) |
Descyclopropyl Lenvatinib |
417719-51-8 |
C18H15ClN4O4 |
![3-Piperidinemethanol, 4-(4-fluorophenyl)-1-methyl-, (3R,4R)-rel-](/CAS/20200611/GIF/54088-21-0.gif) |
3-Piperidinemethanol, 4-(4-fluorophenyl)-1-methyl-, (3R,4R)-rel- |
54088-21-0 |
C13H18FNO |
![1'-Hydroxy Bilastine](/CAS/20211123/GIF/1638785-23-5.gif) |
1'-Hydroxy Bilastine |
1638785-23-5 |
C28H37N3O4 |
![Brexpiprazole Impurity 4](/CAS/20200611/GIF/2116542-20-0.gif) |
Brexpiprazole Impurity 4 |
2116542-20-0 |
C25H27N3O2S |
![Fosaprepitant Impurity 5](/CAS/20210111/GIF/327623-35-8.gif) |
Fosaprepitant Impurity 5 |
327623-35-8 |
C21H19F6NO3 |
![Moxifloxacin Ethyl Ester](/CAS/20180808/GIF/1403836-23-6.gif) |
Moxifloxacin Ethyl Ester |
1403836-23-6 |
C23H28FN3O4 |
![Pantoprazole Impurity 5](/CAS/20210111/GIF/1806469-15-7.gif) |
Pantoprazole Impurity 5 |
1806469-15-7 |
C8H6F2N2O2 |
![Venlafaxine Impurity 5](/CAS/20180531/GIF/1346600-77-8.gif) |
Venlafaxine Impurity 5 |
1346600-77-8 |
C17H27NO2 |
![N-(4-methyl-3-(4-methyl-6-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide](/CAS/20180702/GIF/CB43382316.gif) |
N-(4-methyl-3-(4-methyl-6-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide |
|
C30H33N7O |
![Exemestane impurity B -F](/CAS/20200611/GIF/184972-09-6.gif) |
Exemestane impurity B -F |
184972-09-6 |
C20H26O3 |
![Fesoterodine Impurity 8](/CAS/20200515/GIF/1380491-71-3.gif) |
Fesoterodine Impurity 8 |
1380491-71-3 |
C48H66N2O4 |
![QBWNUEJPRUVNTD-FOIQADDNSA-N](/CAS/20180808/GIF/1346602-17-2.gif) |
QBWNUEJPRUVNTD-FOIQADDNSA-N |
1346602-17-2 |
C22H17N3O5 |
![JZWUWLJCMMPASK-YTSMVRMISA-N](/CAS/20210111/GIF/147103-95-5.gif) |
JZWUWLJCMMPASK-YTSMVRMISA-N |
147103-95-5 |
C24H24N4O7S |
![KXEITTOLAUJQPU-UHFFFAOYSA-N](/CAS/20210111/GIF/1797832-43-9.gif) |
KXEITTOLAUJQPU-UHFFFAOYSA-N |
1797832-43-9 |
C20H21N7O2S |
![GPZGXSFHPLUMHE-KEUNHQLVSA-N](/CAS/20211123/GIF/157054-84-7.gif) |
GPZGXSFHPLUMHE-KEUNHQLVSA-N |
157054-84-7 |
C52H81NO13 |
![IRLGOHSHDYCIAB-ZMVBZRCWSA-N](/CAS/20200611/GIF/1076198-14-5.gif) |
IRLGOHSHDYCIAB-ZMVBZRCWSA-N |
1076198-14-5 |
C19H23F3N2O5 |
![AOEGVETYSHPGBP-XYIDDFOTSA-N](/CAS/20210111/GIF/1887057-05-7.gif) |
AOEGVETYSHPGBP-XYIDDFOTSA-N |
1887057-05-7 |
C41H55NO14 |
![12-Deoxy Roxithromycin](/CAS/20211123/GIF/425365-65-7.gif) |
12-Deoxy Roxithromycin |
425365-65-7 |
C41H76N2O14 |
![1-(1-oxidopyridin-1-ium-2-yl)-1-phenylethanol](/CAS/20200119/GIF/100393-43-9.gif) |
1-(1-oxidopyridin-1-ium-2-yl)-1-phenylethanol |
100393-43-9 |
C13H13NO2 |
![(R)-(R)-1-methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate(WXC03446)](/CAS/20180808/GIF/616866-21-8.gif) |
(R)-(R)-1-methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate(WXC03446) |
616866-21-8 |
C18H25NO3 |
![6'-methyl-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridin]-5-amine](/CAS/20180703/GIF/CB43956117.gif) |
6'-methyl-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridin]-5-amine |
|
C18H17N3O2S |
![Diquafosol Impurity 4](/) |
Diquafosol Impurity 4 |
|
|
![Tofacitinib Impurity X](/) |
Tofacitinib Impurity X |
|
|
![3-pentylideneisobenzofuran-1(3H)-one](/CAS/20180703/GIF/90965-68-7.gif) |
3-pentylideneisobenzofuran-1(3H)-one |
90965-68-7 |
C13H14O2 |
![Labetalol EP impurity E](/) |
Labetalol EP impurity E |
|
|
![1-Propanol, 3-(2-methoxy-5-nitrophenoxy)-](/CAS/20180703/GIF/1156068-41-5.gif) |
1-Propanol, 3-(2-methoxy-5-nitrophenoxy)- |
1156068-41-5 |
C10H13NO5 |
![1616710-52-1](/CAS/20211123/GIF/1616710-52-1.gif) |
1616710-52-1 |
1616710-52-1 |
C27H34N2O6 |
![6-HYDROXY ONDANSETRON](/CAS/GIF/110708-17-3.gif) |
6-HYDROXY ONDANSETRON |
110708-17-3 |
C18H19N3O2 |
![8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one](/CAS/GIF/31251-41-9.gif) |
8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one |
31251-41-9 |
C14H10ClNO |
![(R)-Ornidazole](/CAS/20210305/GIF/166734-80-1.gif) |
(R)-Ornidazole |
166734-80-1 |
C7H10ClN3O3 |
![Bendamustine Related Impurity 22](/) |
Bendamustine Related Impurity 22 |
|
|
![Bendamustine Related Impurity 9](/) |
Bendamustine Related Impurity 9 |
|
|
![Edoxaban Impurity 40](/CAS/20210111/GIF/2081883-52-3.gif) |
Edoxaban Impurity 40 |
2081883-52-3 |
C14H27N3O3 |
![Everolimus Impurity 2](/) |
Everolimus Impurity 2 |
|
|
![Levosimendan Impurity 2 (Mixture ofZandEIsomers)](/) |
Levosimendan Impurity 2 (Mixture ofZandEIsomers) |
|
|
![Solifenacin Related Compound 29](/CAS/20210305/GIF/861998-77-8.gif) |
Solifenacin Related Compound 29 |
861998-77-8 |
C23H26N2O3 |
![Ticagrelor Impurity 31](/) |
Ticagrelor Impurity 31 |
|
|
![Ticagrelor Related Compound 46](/CAS/20210111/GIF/2205903-73-5.gif) |
Ticagrelor Related Compound 46 |
2205903-73-5 |
C28H42ClN9O8S2 |
![Ticagrelor Related Compound 71](/CAS/20200611/GIF/1548397-10-9.gif) |
Ticagrelor Related Compound 71 |
1548397-10-9 |
C7H8ClN3O3S |
![Ticagrelor Related Compound 76](/) |
Ticagrelor Related Compound 76 |
|
|
![Vonoprazan Impurity 25](/) |
Vonoprazan Impurity 25 |
|
|
![Blonanserin Impurity M](/) |
Blonanserin Impurity M |
|
|
![Brexpiprazole Impurity H](/) |
Brexpiprazole Impurity H |
|
|
![Canagliflozin Isomer Impurity 1](/) |
Canagliflozin Isomer Impurity 1 |
|
|
![Celecoxib Impurity 19](/CAS/20200331/GIF/CB54842245.gif) |
Celecoxib Impurity 19 |
|
C17H14F3N3O2S |
![Febuxostat Impurity 81](/) |
Febuxostat Impurity 81 |
|
|
![Gefitinib Impurity Q](/) |
Gefitinib Impurity Q |
|
|
![Irinotecan Impurity 20 HCl](/CAS/20210111/GIF/870527-52-9.gif) |
Irinotecan Impurity 20 HCl |
870527-52-9 |
C20H20N2O4 |
![LCZ696(valsartan + sacubitril) impurity 32](/) |
LCZ696(valsartan + sacubitril) impurity 32 |
|
|
![Lenvatinib Impurity 25](/) |
Lenvatinib Impurity 25 |
|
|
![Leosimendan azide Impurity](/) |
Leosimendan azide Impurity |
|
|
![Regorafenib Impurity 23](/) |
Regorafenib Impurity 23 |
|
|
![Regorafenib Impurity 31](/) |
Regorafenib Impurity 31 |
|
|
![Sitafloxacin Impurity XT-D-01](/) |
Sitafloxacin Impurity XT-D-01 |
|
|
![Sitafloxacin Impurity ZZ-E-01](/) |
Sitafloxacin Impurity ZZ-E-01 |
|
|
![Tofacitinib Impurity 86](/) |
Tofacitinib Impurity 86 |
|
|
![Tofacitinib Impurity 91](/) |
Tofacitinib Impurity 91 |
|
|
![Gefitinib impurity N](/) |
Gefitinib impurity N |
|
|
![Docetaxel Impurity 24](/CAS/20200611/GIF/1217248-58-2.gif) |
Docetaxel Impurity 24 |
1217248-58-2 |
C29H34O9 |
![Olopatadine Impurity 2](/CAS/20200611/GIF/56427-76-0.gif) |
Olopatadine Impurity 2 |
56427-76-0 |
C19H18O4 |
![Pitavastatin Impurity 24 Sodium Salt](/CAS/20211123/GIF/1980814-90-1.gif) |
Pitavastatin Impurity 24 Sodium Salt |
1980814-90-1 |
C25H24FNO6 |
![Ibubinib impurity](/) |
Ibubinib impurity |
|
|
![Oseltamivir Impurity](/CAS/20210111/GIF/212504-89-7.gif) |
Oseltamivir Impurity |
212504-89-7 |
C14H26N2O3 |
![Tofacitinib Impurity QTD](/) |
Tofacitinib Impurity QTD |
|
|
![LCZ696(valsartan + sacubitril) impurity 26](/) |
LCZ696(valsartan + sacubitril) impurity 26 |
|
|
![Cabozantinib impurity 31](/) |
Cabozantinib impurity 31 |
|
|
![Carvedilol Impurity COH](/CAS/20210111/GIF/51997-50-3.gif) |
Carvedilol Impurity COH |
51997-50-3 |
C15H13NO2 |
![Pregabalin Impurity 10](/CAS/20200611/GIF/69680-50-8.gif) |
Pregabalin Impurity 10 |
69680-50-8 |
C7H11NO3 |
![Butyphthalide impurity 51](/) |
Butyphthalide impurity 51 |
|
|
![Canagliflozin Impurity 41](/) |
Canagliflozin Impurity 41 |
|
|
![Pitavastatin Impurity 36](/) |
Pitavastatin Impurity 36 |
|
|
![Pralatrexate Impurity 11](/) |
Pralatrexate Impurity 11 |
|
|
![Pralatrexate Impurity 16](/) |
Pralatrexate Impurity 16 |
|
|
![Pitavastatin Impurity 48](/) |
Pitavastatin Impurity 48 |
|
|
![Pitavastatin Impurity 53](/) |
Pitavastatin Impurity 53 |
|
|
![Lenvatinib Impurity 39](/) |
Lenvatinib Impurity 39 |
2664101-53-3 |
|
![Tazobactam Impurity 10](/) |
Tazobactam Impurity 10 |
|
|
![Crisaborole Impurity 1](/) |
Crisaborole Impurity 1 |
|
|
![Canagliflozin Impurity 57](/) |
Canagliflozin Impurity 57 |
|
|
![Canagliflozin Impurity 62](/) |
Canagliflozin Impurity 62 |
|
|
![Levetiracetam Impurity 22](/) |
Levetiracetam Impurity 22 |
|
|
![Nifekalant Impurity 8](/CAS/20181212/GIF/CB54869952.gif) |
Nifekalant Impurity 8 |
|
|
![Levosimendan Impurity 9](/) |
Levosimendan Impurity 9 |
|
|